InvestorWire NewsRoom

InvestorNewsBreak

InvestorNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Is Revolutionizing Pharmacy Practice Through HealthTab(TM) Platform
September 22, 2021

InvestorNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Is Revolutionizing Pharmacy Practice Through HealthTab(TM) Platform

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is disrupting and revolutionizing the pharmacy practice through its proprietary HealthTab(TM) solution, which sources the best point-of-care analyzers and brings them into a single, secure cloud-based network. A recent article quotes Avricore CEO Hector Bremner as saying, “The power of HealthTab is that it is able to greatly reduce the amount of administration time, extract the results directly out of the machine, merge information, do the complex calculations in order to properly interpret the data, and then produce it in an easy to read format that the patient and professional can interpret quickly and understand the result and then use that to guide their care plan.” HealthTab also boasts a de-identified real-time data attribute that can enable researchers, drug makers, governments and NGOs to use the platform to conduct studies and research in real-time, real-world settings in community pharmacies. Further, “Built on an open API platform, HealthTab can connect to other B2B or B2C health data-focused software. As a result, the platform, which supports easy and quick data transfers, can power third-part health tech products with real-world results and direct diagnostics from pharmacies.”

To view the full article, visit https://ibn.fm/dJjJw

About Avricore Health Inc.

Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM) (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(310) 299-1717

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).